Showing 1 - 20 results of 3,136 for search '(( 50 ppm decrease ) OR ((((( 50 ms decrease ) OR ( 50 nn decrease ))) OR ( 5 wt decrease ))))', query time: 1.24s Refine Results
  1. 1

    Pulse Ultrasound-Based Response Enhancement of a MOX Gas Sensor by Yumin Yang (5737235)

    Published 2024
    “…Comparing the steady responses of five target gases under the pulse and continuous ultrasound, respectively, it is found that the pulse ultrasound causes a better catalysis effect, and response enhancement (RE) by the pulse ultrasound with an optimal pulse width depends on the ultrasonic strength as well as the species and concentration of the target gas. For 2 ppm methanol, the RE by the pulse ultrasound is 50%, relative to the continuous ultrasound, when the pulse width, duty ratio, and working frequency are 0.4 ms, 50%, and 110.1 kHz, respectively. …”
  2. 2

    Pulse Ultrasound-Based Response Enhancement of a MOX Gas Sensor by Yumin Yang (5737235)

    Published 2024
    “…Comparing the steady responses of five target gases under the pulse and continuous ultrasound, respectively, it is found that the pulse ultrasound causes a better catalysis effect, and response enhancement (RE) by the pulse ultrasound with an optimal pulse width depends on the ultrasonic strength as well as the species and concentration of the target gas. For 2 ppm methanol, the RE by the pulse ultrasound is 50%, relative to the continuous ultrasound, when the pulse width, duty ratio, and working frequency are 0.4 ms, 50%, and 110.1 kHz, respectively. …”
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

    Published 2024
    “…<b>C.</b> RT-qPCR of WT1, p<0.05(*), vFLIP(ns), LANA, p<0.0001(****), K8.1, p<0.0001(****), and BCL2 p<0.05(*) in the setting of WT1 knockdown in ISLK BAC-16 with WT1 siRNA in comparison to a control siRNA using two-sided, unpaired student’s t-tests. …”
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

    Published 2021
    “…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20